Mediolanum International Funds Ltd Buys 22,135 Shares of Intuitive Surgical, Inc. $ISRG

Mediolanum International Funds Ltd increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 59,398 shares of the medical equipment provider’s stock after purchasing an additional 22,135 shares during the period. Mediolanum International Funds Ltd’s holdings in Intuitive Surgical were worth $31,701,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Norway Savings Bank lifted its holdings in Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after purchasing an additional 910 shares during the last quarter. Trust Co. of Oklahoma bought a new position in shares of Intuitive Surgical in the second quarter valued at approximately $363,000. IronOak Wealth LLC. acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $1,099,000. Amalgamated Bank increased its holdings in Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after purchasing an additional 1,772 shares in the last quarter. Finally, Neville Rodie & Shaw Inc. increased its holdings in Intuitive Surgical by 11.9% during the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $552.23 on Friday. The company has a fifty day moving average price of $489.85 and a two-hundred day moving average price of $504.10. The firm has a market capitalization of $197.96 billion, a PE ratio of 73.05, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.84 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity

In related news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. This trade represents a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. The trade was a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 116,164 shares of company stock valued at $61,916,172. Insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ISRG shares. Mizuho set a $575.00 price target on Intuitive Surgical in a report on Wednesday, October 22nd. Daiwa Capital Markets boosted their target price on shares of Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. HSBC increased their price target on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Argus boosted their price objective on shares of Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Finally, Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.